23andMe

23andMe Says 15% of Customers Asked To Delete Their Genetic Data Since Bankruptcy

23andMe says 15% of customers asked to delete their genetic data since bankruptcy

23andMe’s DNA Data Soars in Value With New $305 Million Bid

Regeneron Pharmaceuticals To Buy 23andMe and Its Data For $256 Million

Struggling DNA testing firm 23andMe to be bought for $256m

Regeneron Pharmaceuticals to buy 23andMe and its data for $256 million

23andMe bought by Regeneron in court auction

23andMe Sells Gene-Testing Business to DNA Drug Maker Regeneron

Pharma giant Regeneron to buy 23andMe and its customers’ data for $256M

23andMe Requiring Potential Bidders To Affirm They Will Uphold Data Privacy

Engadget Podcast: Signalgate and the collapse of 23andMe

23andMe Says ‘Delays’ Resolved After Users Rushed to Delete Data

23andMe is bankrupt and about to sell your DNA, here's how to stop that from happening

23andMe has filed for bankruptcy and CEO Anne Wojcicki has stepped down

23andMe's genes not strong enough to avoid Chapter 11

23andMe faces an uncertain future — so does your genetic data

23andMe Goes Bankrupt as Only 550,000 Subscribe to Gene Testing

The fall of 23andMe: How DNA testing lost its way

23andMe must secure its DNA databases immediately

23andMe lays off 40% of its workforce, ends therapeutics division